Commercial, legal, political, and scientific trends in biotechnology

Currently:

About the Author

Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books. He is also founder of DrugPatentWatch, and managing editor of the Journal of Commercial Biotechnology.

Read More...

Biotech is benign

Friday, 6th June 2003

General Biotechnology

Biotech is benign
Europe’s continued blocking of GM imports is illegal, unjustified and founded on ignorance.

Leave a Comment